Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug

Figure 1

Chemical structure of parent compound 97/78, in vivo active metabolites 97/63, and IS (α-arteether).